CINECA IRIS Institutional Research Information System

SICILIANO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.266
EU - Europa 15.690
AS - Asia 5.138
AF - Africa 751
OC - Oceania 79
SA - Sud America 53
Continente sconosciuto - Info sul continente non disponibili 8
Totale 58.985
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.158
IT - Italia 7.014
CA - Canada 3.080
SE - Svezia 2.465
CN - Cina 2.380
DE - Germania 1.695
BG - Bulgaria 1.460
SG - Singapore 974
GB - Regno Unito 725
TR - Turchia 638
VN - Vietnam 583
UA - Ucraina 579
FI - Finlandia 503
CI - Costa d'Avorio 492
AT - Austria 317
CH - Svizzera 260
HK - Hong Kong 216
IN - India 188
RU - Federazione Russa 179
SN - Senegal 135
FR - Francia 120
NG - Nigeria 117
BE - Belgio 93
IL - Israele 50
NL - Olanda 45
NZ - Nuova Zelanda 42
PL - Polonia 42
CZ - Repubblica Ceca 40
AU - Australia 37
ES - Italia 36
JP - Giappone 25
IR - Iran 23
MX - Messico 23
GR - Grecia 22
IE - Irlanda 19
BR - Brasile 18
HU - Ungheria 17
DK - Danimarca 15
TW - Taiwan 12
AR - Argentina 10
EC - Ecuador 10
KR - Corea 9
CL - Cile 7
EU - Europa 7
ID - Indonesia 6
PE - Perù 6
PT - Portogallo 6
RO - Romania 6
BD - Bangladesh 5
EE - Estonia 5
TH - Thailandia 5
HR - Croazia 4
OM - Oman 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
BA - Bosnia-Erzegovina 3
LT - Lituania 3
MY - Malesia 3
NO - Norvegia 3
PH - Filippine 3
SA - Arabia Saudita 3
CO - Colombia 2
EG - Egitto 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LV - Lettonia 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
DM - Dominica 1
DZ - Algeria 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
MC - Monaco 1
MD - Moldavia 1
ME - Montenegro 1
MT - Malta 1
NI - Nicaragua 1
PK - Pakistan 1
SV - El Salvador 1
UZ - Uzbekistan 1
Totale 58.985
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.588
Fairfield 3.780
Houston 3.773
Ann Arbor 3.389
Chandler 2.772
Montreal 2.303
Ashburn 1.830
Seattle 1.755
Milan 1.477
Sofia 1.459
Wilmington 1.332
Serra 1.306
Cambridge 1.270
New York 943
Beijing 933
Jacksonville 789
Ottawa 740
Princeton 666
Izmir 617
Lawrence 594
Medford 551
Abidjan 492
Nanjing 429
Florence 410
Singapore 362
Des Moines 325
Rome 321
Vienna 304
Bern 233
Dong Ket 226
Pisa 209
San Diego 208
Hong Kong 196
Frankfurt am Main 192
Dearborn 188
Nanchang 182
London 176
Ogden 173
Jüchen 151
Bremen 142
Dakar 135
Redwood City 135
Lagos 116
Kunming 100
Norwalk 98
Hebei 93
Lancaster 88
Shenyang 86
Brussels 81
Changsha 80
Pune 67
Los Angeles 66
Boulder 63
Livorno 62
Falls Church 59
Jiaxing 59
Tianjin 58
Boardman 55
Chicago 51
Washington 49
Naples 48
Nürnberg 46
Vicopisano 46
Detroit 39
Hefei 39
Warsaw 39
Orange 37
Auburn Hills 34
Genoa 33
Düsseldorf 32
Fondi 32
Hangzhou 30
Kent 30
Brno 28
Dallas 28
San Francisco 28
Turin 28
Bergamo 25
Bologna 25
Guangzhou 25
Jinan 24
Hyderabad 23
Verona 23
Changchun 22
Lanzhou 22
Lappeenranta 22
Phoenix 21
Trieste 21
Bari 19
Lucca 19
Palermo 19
Edinburgh 18
Madrid 17
Munich 17
Auckland 16
Budapest 16
Christchurch 16
Padova 16
Costa Mesa 15
Dublin 15
Totale 45.440
Salva come PNG Salva come JPEG
Nome #
A Clinical Tool for Prognosis and Speech Rehabilitation in Dysarthric Patients: The DESIRE Project 2.338
Stima della prevalenza della sclerosi laterale amiotrofica (SLA): elaborazione di un algoritmo dai dati sanitari routinari 1.759
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 242
Serum gamma-glutamyltransferase fractions in myotonic dystrophy type I: differences with healthy subjects and patients with liver disease 216
Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease 215
Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: report of a family 183
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 182
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects 176
Polymorphisms in folate and homocysteine metabolizing genes and chromosome damage in mothers of Down syndrome children 174
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 173
Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality? 172
The role of mitochondria in stem cell biology 169
Mitochondrial DNA-related disorders 168
Antimyoclonic effect of levetiracetam in MERRF syndrome 166
Mitochondria, cognitive impairment, and Alzheimer's disease. 166
Dream recall in patients with focal cerebral lesions. 165
A case of pelvic floor myoclonic jerk syndrome. 161
Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer's Disease. 159
The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects 158
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases 157
An atypical presentation of sporadic adult-onset centronuclear myopathy 156
Mitochondrial non-syndromic sensorineural hearing loss: a clinical, audiological and pathological study from Italy, and revision of the literature 155
A novel mitochondrial tRNA(Ile) point mutation associated with chronic progressive external ophthalmoplegia and hyperCKemia. 155
Inflammatory myopathy in a patient with postural and kinetik tremor. 154
Metabolic myopathies: functional evaluation by different exercise testing approaches 154
Effects of anticholinergic agents on the excitability of the blink reflex in Meige syndrome. 152
Diagnostic Approach to Mitochondrial Disorders: the Need for a Reliable Biomarker 151
Nerve and muscle involvement in mitochondrial disorders: an electrophysiological study. 151
Dysphagia in Amyotrophic Lateral Sclerosis: relationshisp between disease progression and fiberoptic endoscopic evaluation of swallowing. 149
Clinical Trials for Neuroprotection in ALS 149
A novel mitochondrial tRNAPhe mutation causes MERRF syndrome 149
A STANDARDIZED CLINICAL EVALUATION OF PATIENTS AFFECTED BY FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: THE FSHD CLINICAL SCORE 148
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 148
Tarsal tunnel syndrome in seronegative spondyloarthropathy. 147
Mapping Cortical Degeneration in ALS with Magnetization Transfer Ratio and Voxel-Based Morphometry 147
Psychiatric involvement in adult patients with mitochondrial disease. 147
High-resolution 7T MR imaging of the motor cortex in amyotrophic lateral sclerosis 147
Association study between XRCC1 gene polymorphisms and sporadic amyotrophic lateral sclerosis 146
CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease 145
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 145
Oxidative stress in cerebral small vessel disease dizziness patients, basally and after polyphenol compound supplementation 145
Nerve, muscle and heart acute toxicity following oxaliplatin and capecitabine treatment. 145
.Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first? 144
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment. 144
Sleep Disorders in an elderly population and their relationship with cognitive symptoms: an epidemiological survey 144
Oxidative stress treatment for clinical trials in neurodegenerative diseases. 143
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise 143
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease 142
Astrocyte-neuron interactions in neurological disorders 142
Mitochondrial DNA haplogroups may influence Fabry disease phenotype 142
Mitochondrial DNA single deletion in a patient with postural tremor. 141
Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease. 140
Mitochondria and neurodegeneration 140
Reply to P.M. Foye ( Letter ) 140
Progressive sensorineural hearing loss in childhood 140
Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis 140
Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy. 139
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral sclerosis 139
Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier 139
DNMT3B promoter polymorphisms and risk of late onset Alzheimer's disease. 139
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany 139
Epilepsy and limb girdle muscular dystrophy type 2A: double trouble, serendipitous finding or new phenotype? 137
Impaired oxidative metabolism in exercising muscle from ALS patients. 137
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 137
Mitochondrial peripheral benzodiazepine receptor in amyotrophic lateral sclerosis 136
Is erythropoietin gene a modifier factor in amyotrophic lateral sclerosis? 136
Facioscapulohumeral muscular dystrophy type 1A in northwestern Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 136
A mitochondrial tRNAPhe mutation causes MERRF syndrome [Sindrome MERRF associata a mutazione del tRNAPhe] 135
Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients 135
The hOGG1 Ser326Cys polymorphism and Huntington's disease 135
Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal ig synthesis in multiple sclerosis patients 135
Missense and splice site mutations in SPG4 suggest loss-of-function in dominant spastic paraplegia. 134
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 134
Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction 133
Oxidative stress modulation in neurodegenerative diseases 133
Variability of the expression of muscle mitochondrial damage in ocular mitochondrial myopathy. 133
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany 133
Mitochondrial dysfunction and Alzheimer's disease: new developments 132
Drugs and mitochondrial diseases: 40 queries and answers. 132
Coenzyme Q10, exercise lactate and CTG trinucleotide expansion in myotonic dystrophy 132
May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease? 132
The role of mitochondria in stem cell biology 132
The Role of Mitochondria in StemCell Biology 131
A new truncating MPZ mutation associated with a very mild CMT1 B phenotype 131
Tetracycline treatment in patients with progressive external ophthalmoplegia. 130
Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT-II deficiency. 130
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic Amyotrophic Lateral Sclerosis 130
Gly482Ser PGC-1α gene polymorphism and exercise-related oxidative stress in amyotrophic lateral sclerosis patients 130
Thyroid function and oral TRH in amyotrophic lateral sclerosis 129
Lack of association between nuclear factor erythroid-derived 2-like 2 promoter gene polymorphisms and oxidative stress biomarkers in amyotrophic lateral sclerosis patients 128
New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy. 127
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes 127
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 127
Amyotrophic lateral sclerosis with long lasting disease course and SOD1 and TARDBP mutations: Report of two cases and overview of the literature. 127
Alteration of lactate production during incremental excercise in myotonic dystrophy is not dependent by catecholamine increase 126
Coenzyme Q10 in neuromuscular and neurodegenerative disorders 126
.Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA. 126
The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study 126
Pes cavus and hereditary neuropathies: when a relationship should be suspected. 125
Abnormal levels of human mitochondrial transcription factor A in skeletal muscle in mitochondrial encephalomyopathies. 125
Totale 18.384
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.281
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.281
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209.691 0 843 1.227 636 977 1.056 1.183 811 1.173 723 871 191
2020/20214.646 406 275 293 255 452 272 337 435 439 399 331 752
2021/20226.582 134 390 182 434 1.180 842 183 403 308 218 486 1.822
2022/20239.156 953 1.140 602 813 1.028 1.071 110 674 1.669 106 807 183
2023/20249.949 844 781 882 509 1.050 1.253 400 263 178 2.578 446 765
2024/2025222 195 27 0 0 0 0 0 0 0 0 0 0
Totale 59.932